Drs Michelle M. Kittleson and Gregg Fonarow share need-to-know nuances on initiating four HFrEF therapies in select patients.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982149). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
The Use of β-Blockers in Heart Failure With Reduced Ejection Fraction https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468030/
Vericiguat in Patients With Heart Failure and Reduced Ejection Fraction https://pubmed.ncbi.nlm.nih.gov/32222134/
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103045/
Transcatheter Mitral-Valve Repair in Patients With Heart Failure https://pubmed.ncbi.nlm.nih.gov/30280640/
